Profil
Mr. Ian Davenport is Operating Advisor at Ennovance Capital LLC.
Prior to joining Ennovance, Mr. Davenport was a Senior Executive at Dow Chemical with P&L responsibility (now a $1B+ business) and over 25 years of general leadership experience.
He held various senior management positions ranging from Global Business Director to Global Sales & Marketing to General Management.
His achievements include major business turnarounds, repeated successes in new business development, and the development and implementation of strategies leading to value creating acquisitions.
Mr. Davenport holds a B.A. & M.A. in Natural Sciences in Chemistry from Cambridge University.
Aktive Positionen von Ian Davenport
| Unternehmen | Position | Beginn |
|---|---|---|
Ennovance Capital LLC
Ennovance Capital LLC Investment ManagersFinance Ennovance Capital invests in middle market companies located in the United States. The firm focuses on companies operating in the fields of chemicals, allied products, healthcare and related specialty material sectors. It provides financing for growth stage capital requirements with investment size of USD 200 million and above. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Ian Davenport
| Unternehmen | Position | Ende |
|---|---|---|
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Ausbildung von Ian Davenport
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ennovance Capital LLC
Ennovance Capital LLC Investment ManagersFinance Ennovance Capital invests in middle market companies located in the United States. The firm focuses on companies operating in the fields of chemicals, allied products, healthcare and related specialty material sectors. It provides financing for growth stage capital requirements with investment size of USD 200 million and above. | Finance |
















